Long-term ω-3 fatty acid supplementation induces anti-stress effects and improves learning in rats by Miguel Á Pérez et al.
Pérez et al. Behavioral and Brain Functions 2013, 9:25
http://www.behavioralandbrainfunctions.com/content/9/1/25RESEARCH Open AccessLong-term ω-3 fatty acid supplementation
induces anti-stress effects and improves learning
in rats
Miguel Á Pérez1,2, Gonzalo Terreros1 and Alexies Dagnino-Subiabre1*Abstract
Chronic stress leads to secretion of the adrenal steroid hormone corticosterone, inducing hippocampal atrophy and
dendritic hypertrophy in the rat amygdala. Both alterations have been correlated with memory impairment and
increased anxiety. Supplementation with ω-3 fatty acids improves memory and learning in rats. The aim of this
study was to evaluate the effects of ω-3 supplementation on learning and major biological and behavioral stress
markers. Male Sprague–Dawley rats were randomly assigned to three experimental groups: 1) Control, 2) Vehicle,
animals supplemented with water, and 3) ω-3, rats supplemented with ω-3 (100 mg of DHA+25 mg of EPA). Each
experimental group was divided into two subgroups: one of which was not subjected to stress while the other was
subjected to a restraint stress paradigm. Afterwards, learning was analyzed by avoidance conditioning. As well,
plasma corticosterone levels and anxiety were evaluated as stress markers, respectively by ELISA and the plus-maze
test. Restraint stress impaired learning and increased both corticosterone levels and the number of entries into the
open-arm (elevated plus-maze). These alterations were prevented by ω-3 supplementation. Thus, our results
demonstrate that ω-3 supplementation had two beneficial effects on the stressed rats, a strong anti-stress effect
and improved learning.
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Stress is a complex biological reaction common to all living
organisms that allows them to adapt to environmental pres-
sure (i.e., stressors) [1,2]. Stress responses are mainly medi-
ated by the activation of the hypothalamic-pituitary-adrenal
(HPA) axis, leading to secretion of glucocorticoids from the
adrenal gland; glucocorticoids are bound to glucocorticoid
receptors in peripheral tissues and the brain to regulate
stress responses [3-5]. Stressors increase the release of cor-
ticotrophin releasing factor (CRF) from the hypothamus,
inducing adrenocorticotropic hormone release from the
anterior pituitary, which in turn stimulates the secretion of
corticosterone from the adrenal cortex [6]. Corticosterone
is bound to glucocorticoid receptors (GRs) in peripheral
tissues and the brain [3,5,7]. The hippocampus, amygdala* Correspondence: alexies.dagnino@uv.cl
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reproduction in any medium, provided the orand medial prefrontal cortex have high concentrations of
GRs [8-10]. Chronic glucocorticoid treatment induces den-
dritic atrophy in the hippocampus [11-13] and medial pre-
frontal cortex [13], while acute corticosterone treatment
induces dendritic hypertrophy in the basolateral amygdal-
oid nucleus and enhances anxiety [14-16].
Chronic stress and corticosterone treatment affect the
dendritic morphology of limbic areas of the rat brain,
such as the hippocampus, amygdaloid complex, and pre-
frontal cortex [17-19]. These alterations increase anxiety,
and impair both memory and spatial learning [20-22].
Anxiety is an adaptive reaction induced when an animal
is confronted with potential demands and dangers. In-
deed, anxiety has a key biological-adaptive role, which is
highly conserved during evolution [23]. Excessive or
pathological levels of anxiety induce maladaptive re-
sponses [23]. In humans, chronic stress or psychosocial
stress also produces hippocampal volume atrophy [24]
and functional changes in the prefrontal cortex [25].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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auditory cue (conditioned stimulus, CS) with an aversive
unconditioned stimulus (US). Once learned, the CS will
by itself elicit a conditioned response. For instance,
freezing is a conditioned response to fear in two-way sig-
naled active avoidance conditioning (2-AA). Rats are
trained in a shuttle box to avoid a foot shock signaled by
an auditory cue [26]. Chronic restraint stress impaired
the learning in the 2-AA and the neuronal morphology
of the auditory system [27,28].
There is abundant evidence that chronic stress and/or
diet affects the brain physiology in animal models as well
as in humans. However, the interaction between stress
and diet is poorly understood [29]. Docosahexaenoic
acid (22:6 ω-3; DHA) is a predominant dietary ω-3 poly-
unsaturated fatty acid (PUFAs) that improves learning
by animals in the 2-AA paradigm [30]. Conversely, rats
subjected to maternal separation and a ω-3 PUFA-
deficient diet are more anxious and fearful than control
animals [31]. Long-term EPA and DHA supplementation
decreases anger and anxiety in animal models of drug
addiction [32,33]. In humans, PUFAs have positive effects
on the pathophysiology of a wide range of stress-related
disorders [32,34-37]. Patients suffering major depression,
a stress-related disorder, have shown reductions in the
plasma levels of ω-3 PUFAs, without any change in fatty
acid ω-6 levels [38-41].
These findings suggest that long-term ω-3 supplementa-
tion of the diet of post-weaning animals has two effects on
chronically stressed rats: preventing the stress-induced
learning impairment in a 2-AA test and decreasing plasma
corticosterone levels and anxiety. The objective of this
study was to analyze the effects of a DHA and EPA
mix on learning, corticosterone levels and anxiety of




Male Sprague–Dawley rats (80–100 g, 21 days old at the
start of the experiment) were housed in groups of three
animals per cage, under a 12/12 light/dark cycle (lights
on at 8:00 am). They were maintained in a temperatureFigure 1 Schematic drawing of the experimental design. Experimental
acids supplementation). Restraint stress was applied from PND 36 to 57; EPand humidity controlled room (20 ± 1°C, 55%) and
weighed every day on a digital scale (Model WLC2/A1,
Radwag, Poland). All procedures relating to animal experi-
mentation were in strict accordance with animal care
standards outlined in the National Institute of Health
(USA) guidelines and approved by the Institutional Ani-
mal Ethics Committee of the Universidad de Valparaíso
and Universidad Católica del Norte. Efforts were made to
minimize the number of animals used and their suffering.
Experimental design
Figure 1 shows a schematic drawing of the experimental
design used in this study. Rats were maintained with ad
libitum access to food (rat chow, Champion®, Santiago,
Chile) and water during all experiments. Each rat ate be-
tween 15–30 g of rat chow per day; 0.34% of 1 g of rat
chow was ω-3 fatty acids. Rats were randomly assigned
into three experimental groups for supplementation: Con-
trol (n = 60), animals did not receive supplementation;
Vehicle (n = 60), rats were supplemented daily with 2.5 ml
of water by oral administration; and ω-3-supplemented
animals (n = 60), which were supplemented daily with
2.5 ml of a mix of 100 mg of DHA and 25 mg of EPA per
kg animal weight by oral administration (Knop Laborator-
ies S.A. Santiago, Chile). Supplementation was applied
once per day; the rat was picked up from its home cage
and gently held in the hand of the experimenter for the
oral administration of vehicle or ω-3. The procedure took
approximately one minute. Animals from the vehicle and
ω-3 groups received water or ω-3 fatty acids respectively
between postnatal days (PND) 21 and 61 (Figure 1). Each
experimental group was divided into two subgroups: one of
which was not subjected to any type of stress [control + un-
stressed (U), C-U, n = 30; vehicle + unstressed, V-U, n = 30;
ω-3 + unstressed, ω-3-U, n = 30], while the other one was
subjected to a restraint-stress protocol (control +
stress, C-S, n = 30; vehicle + stress, V-S, n = 30; ω-3 +
stress, ω-3-S, n = 30). Stressed and unstressed animals
were littermates and after weaning were housed in sep-
arate rooms. Unstressed rats were never exposed to
stressed and the restraint stress was applied in differ-
ent room. Table 1 shows the number of animals used
in each experiment.time line (not to scale) from Post Natal Day (PND) 21 to 61 (ω-3 fatty
M: elevated plus maze test; 2-AA: Active avoidance conditioning test.
Table 1 Number of rats used in each experiment
Unstressed rats Stressed rats
Experiment Control Vehicle ω-3 Control Vehicle ω-3 Total
Locomotor activities and Anxiety n = 9 n = 9 n = 9 n = 9 n = 9 n = 9 n = 54
CORT levels in unstimulated rats n = 6 n = 6 n = 6 n = 6 n = 6 n = 6 n = 36
CORT levels after acute swim n = 6 n = 6 n = 6 n = 6 n = 6 n = 6 n = 36
Learning (active avoidance conditioning) n = 9 n = 9 n = 9 n = 9 n = 9 n = 9 n = 54
Total 30 30 30 30 30 30 n = 180
Pérez et al. Behavioral and Brain Functions 2013, 9:25 Page 3 of 12
http://www.behavioralandbrainfunctions.com/content/9/1/25Handling procedure and restraint stress
Rats were removed every day by hand and transferred to
another cage on the pan of a balance to be weighed. Dif-
ferent investigators did this procedure from those apply-
ing the restraint stress. All rats in every group were
handled with the same procedures. Animals were placed
in acrylic restrainers (6 cm wide × 12 cm long and then
6 cm wide × 20 cm long as the rats grew) in their home
cages. They were subject to restriction for 6 h every day,
beginning at 10 am, from the 36 to 57 PND (21 days of
restraint stress). Restrainers were perforated at each end
to allow ventilation and avoid overheating the animals.
During the stress protocol, animals could breathe with-
out difficulty and urinate and defecate without being in
constant contact with their wastes. The following add-
itional parameters were measured to monitor the over-
all effects of the stress protocol: percentage gain in
body weight, plasma corticosterone levels, and anxiety
(see below).
Behavioral procedures
On day one and day two after the end of the stress
protocol rats were analyzed individually in the open field
and the EPM respectively. A separate set of rats was
used for this experiment (C-U, n = 9; C-S, n = 9; V-U, n = 9;
V-S, n = 9; ω-3-U, n = 9; ω-3-S, n = 9). Behavioral tests were
carried out from 10 am to 2 pm in the test room. The activ-
ity of each rat was recorded by Internet Protocol (IP) cam-
eras (VIVOTEK, Sunnyvale CA, USA) fixed above the
behavioral apparatus and connected to a computer in an-
other room. Videos were acquired by Nuuo software (Nuuo,
Taipei, Taiwan) and analyzed with ANY-maze video tracking
system (Stoelting Co., IL, USA). Mazes were wiped and
cleaned with 5% ethanol solution after each trial. In all ex-
periments, animals from control and stress groups were
evaluated at the same time.
Open field test
Behavior tests were conducted in a soundproof and
temperature-controlled (21 ± 1°C) room. Each rat was
placed in the center of a black Plexiglass cage (70 × 70 ×
40 cm) for 5 min. The background noise level in the
open field was 40 dB (Precision sound level meter,
Model # 1100, Quest Technologies, Oconomowoc, WI)and the arena was illuminated by 300 ± 20 lux (mea-
sured by a digital lux meter, Model # LX-1010B, Weafo
Instrument Co., Shanghai, China). The total distance
travelled and average speed were determined from the
video recordings and analyzed with the ANY-maze video
tracking system (Stoelting Co., IL, USA).
Elevated Plus-Maze (EPM)
Twenty-four hours after the open field test, we mea-
sured anxiety levels using an EPM test. Each rat was
placed individually in an EPM, consisting of two open
arms (60 × 15 cm each), two closed arms (60 × 15 ×
20 cm each) and a central platform (15 × 15 cm) ar-
ranged so that the two arms of each type were opposite
to each other. The maze was elevated 100 cm above the
floor. The illumination was 300 ± 10 luxs in the open
arms and 210 ± 10 luxs in the closed arms. At the begin-
ning of each trial, animals were placed at the center of
the maze, facing an open arm. During a 5-min test
period we recorded the frequency of entries to the
open and closed arms. The percentage of entries and
the ratio of open to total arm entries (open/total×100)
were used as measures of the anxiety level. Total arm
entries were taken as an indicator of general locomotor
activity. Entry into an arm was defined as having oc-
curred when the animal placed all four limbs onto the
arm.
Active avoidance conditioning (2-AA)
Apparatus
Rats were trained in a shuttle box (50 × 25 × 25 cm3)
that was divided into two identical stainless steel modu-
lar testing units by a black Plexiglas divider. The divider
had a narrow passage (8 cm) opened between the sec-
tions. The grid floor had 38 stainless steel bars arranged
parallel to the dividers (Panlab Instruments, Barcelona,
Spain). A 3-kHz 80-dB tone was presented to subjects as
a conditioned stimulus (CS) signaling the upcoming un-
conditioned stimulus (US) in the form of a foot shock
(0.5 mA) delivered by a shocker (LE 100–26, Panlab S.L.,
Barcelona, Spain). The CS was delivered simultaneously
by speakers located on opposite walls of the chamber
(20 cm high). Both the CS and US stimuli were regu-
lated by Shutavoid software (Panlab S.L., Barcelona,
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sound-attenuating box. The inside of the box was dimly il-
luminated with a 0.5-W LED bulb.
Behavioral training
A separate set of rats was used for this experiment (C-U,
n = 9; C-S, n = 9; V-U, n = 9; V-S, n = 9; ω-3-U, n = 9;
ω-3-S, n = 9). The rats were placed in the shuttle box
and trained individually. During the training sessions the
rats were subjected to a 5-min stimulus-free acclimation
period. On day 1, all rats were first exposed to a 5-min
acclimation period, followed by the habituation trials
(habituation) where rats received a CS tone for 20 sec,
with an average inter-trial interval (ITI) of 30 s without
presenting the US. Rats were then returned to their
home cages. On day 2 (conditioning day 1), after an ac-
climation period, rats received 100 signaled avoidance
trials with an average ITI of 30 sec. Each trial consisted
of 20 sec of CS, the last 10 sec of which coincided with
a 10-sec US. Shuttling action by the rat cut the tone im-
mediately and prevented the foot shock. If there was no
shuttling during the 20-sec tone, the foot shock was
applied until the rat shuttled (escape response) or the
shock continued for a maximum of 10 sec. Rats were
then returned to their home cages for 24 h. On day 3
(conditioning day 2), rats were returned to the cham-
ber and received 50 signaled avoidance trials with an
average ITI of 30 sec, the last 10 sec of which over-
lapped with a 0.5-mA foot shock (maximum shock
duration of 10 s) until the animal escaped to the op-
posite chamber.
Behavioral measurement
All animal movements were recorded by IP cameras
mounted inside the sound-attenuating box. Conditioned
avoidance response (CR) was defined as the rat crossing
to the opposite chamber within the first 10 s after the
tone started. One hundred and fifty training trials were
applied to all animals on days 2 and 3, which were di-
vided into fifteen blocks of 10 trials each. The number
of CRs was measured in each block of trials and the per-
centage of CRs (% CR) was calculated [(number of CR/10
training trials)×100]. All data were measured by Shutavoid
software (Panlab S.L., Barcelona, Spain).
Plasma corticosterone measurement by ELISA
This experiment analyzed whether restraint stress affects
the stress levels of the rats one day after the stress had
ended. The most conventional method to determine if
animals are stressed is to measure the plasma levels of
the stress hormone corticosterone. Stressed animals
show an increase in HPA axis activity and plasma cor-
ticosterone levels compared to controls after exposure
to an uncontrollable stressor, leading to maladaptiveresponses [42]. In this way, acute swim stress in a
water maze increases plasma corticosterone levels of
Sprague–Dawley rats [43]. Therefore, we measured the
plasma corticosterone levels of the rats one day after
of the last restraint session, when behavioral experi-
ments were initially conducted.
Animals were subjected to a new stressor (swimming
in a water maze) and corticosterone plasma levels were
quantified before and after water maze exposure.
A separate set of animals was used to measure the con-
centration of corticosterone in plasma to avoid the stressful-
ness of blood collection being a contaminating factor in the
behavioral experiments. One set of rats (C-U, n = 6, C-S,
n = 6, V-U, n = 6, V-S, n = 6, ω-3-U, n = 6, ω-3-S, n = 6)
was given a 60 s probe trial in a water maze at 11 am after
which the animals were transferred to a heated holding
cage for 10 minutes. Afterward, the animals were taken to
a separate room (time used approximately 10 s) and
quickly anesthetized with isoflurane (time used approxi-
mately 5 s) and immediately sacrificed via decapitation
under deep anesthesia for blood collection. Animals were
not exposed to other decapitated animals before being
anesthetized. Another set of rats (C-U, n = 6, C-S, n = 6,
V-U, n = 6, V-S, n = 6, ω-3-U, n = 6, ω-3-S, n = 6) was not
disturbed and was sacrificed at 11:11 am under deep
anesthesia. The Morris water maze consisted of a blue cir-
cular tank (183 cm diameter) in a room that was rich with
spatial cues. The tank contained non-toxic colored water
at 19°C (black non-toxic tempura paint).
Blood (1 ml) was collected in heparinized tubes,
centrifuged at 3,000 rpm (Model # MiniSpin Plus;
Eppendorf AG, Hamburg, Germany) for 20 min to ob-
tain plasma, which was then stored at −70°C. Total cor-
ticosterone was determined by an Enzyme Immunoassay
kit (CorticosteroneBioAssay™, Catalog. # C7903-30) pur-
chased from US Biological (Swampscott, MA). Optical
density values were measured at 450 nm using a micro-
plate reader (Model # Anthos 2010 Microplate Reader,
Biochrom Ltd, UK). Samples were diluted 1:10 and
processed in duplicates. Averaged final values were rep-
resented as μg/dL.
Statistical analysis
Open field test and percentage of body weight gain
Time, total distance travelled, and average speeds were an-
alyzed with the Student’s t-test. Percentage of body weight
gain was analyzed using a two-way repeated-measures
ANOVA [groups (control, stress) × days (1, 7, 14, 21)]
followed by Bonferroni post-hoc comparison tests. A two-
way ANOVA compared groups for anxiety levels in the
open field test. The dependent variable for anxiety was the
time spent in the center of the open field and the inde-
pendent variables were restraint stress (unstressed and
stressed) and the diet (control, vehicle and ω-3).
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A two-way ANOVA compared groups for anxiety levels
in the plus-maze. The dependent variable for anxiety
was the percentage of open-arm entries and the inde-
pendent variables were restraint stress (unstressed and
stressed) and diet (control, vehicle and ω-3). The cor-
ticosterone levels were analyzed by a 3 × 2 factorial
ANOVA.
Active avoidance
The CR percentage was analyzed with a two-way repeated-
measures ANOVA [groups (control, stress)×trials (habitu-
ation, conditioning day 1, conditioning day 2)] followed by
a Bonferroni post-hoc comparisons test. Data from the
% CR were transformed to arcsine [(arcsine of square root
of (% CR/100)] to satisfy requirements of the ANOVAmodel
and then the slopes were analyzed by regression analysis.
Results
Body weight gain and locomotor activity
The two-way repeated-measures ANOVA showed that
chronic restraint stress significantly reduced body weight
gain beginning on PND 21 (F(1,48) = 35.61, p < 0.0001)
(Figure 2A). There was a main effect of diet and inter-
action on body weight gain, where the post-hoc test
showed that rats subjected to restraint stress from both
control and ω-3 diet groups had significantly decreased
body weight gain compared to the respective unstressed
controls (F(1,48) = 1559, p < 0.0001). Conversely, body
weight gain of rats from the vehicle (diet) group
subjected to restraint stress was not affected compared
to unstressed rats from the vehicle group (Figure 2A).
Figure 2B shows body weight gain at PND 21 (same data
as in Figure 2A). There was a main effect of both stress
and diet where the body weight gain of rats subjected to
the stress protocol was significantly lower (F(2,48) =
35.612, p < 0.0001), while rats subjected to stress that re-
ceived supplements (vehicle and ω-3 diet) had signifi-
cantly lower body weight gain than rats on the controlFigure 2 Effect of chronic restraint stress on body weight gain. Rats s
in body weight gain were observed from day 7 between stressed and uns
animals from the vehicle groups (A). In contrast, unstressed rats gained we
represented as means ± SEM. An asterisk (*) indicates significant differencediet (F(2,48) = 48.701, p < 0.0001). There was a significant
effect of the diet-stress interaction on body weight gain
(F(2,48) = 3.46, p < 0.05). The post-hoc test showed that
rats of the control and ω-3 groups that were subjected
to restraint stress had significantly lower body weight
gain than unstressed rats (F(2,48) = 3.46, p < 0.001).
Conversely, restraint stress did not affect the body
weight gain of animals in the vehicle group (F(2,48)=
3.46, p = 0.849).
Restraint stress did not affect locomotor activity levels
(total distance traveled and average speed) in any experi-
mental group (Table 2). Restraint stress significantly re-
duced time spent in the center of open field among
control and vehicle groups rats (F(1,48) = 9.06, p < 0.01),
while stress did not affect ω-3 group rats. Animals of
the vehicle group spent significantly more time in the
center of open field than control group rats (F(2,48) =
4.93, p < 0.01). A two-way ANOVA did not show an
interaction between restraint stress and diet (Table 2).
Effect of ω-3 fatty acids supplementation on anxiety and
corticosterone plasma levels
Restraint stress and vehicle treatment significantly de-
creased the percentage of open-arm entries (control
group: stressed rats: 32.42 ± 6.24 entries, unstressed rats:
67.58 ± 6.24 entries, p = 0.002; vehicle group: stressed
rats: 39.44 ± 7.63 entries, unstressed rats: 60.56 ± 7.64
entries; p > 0.150). This effect was prevented with ω-3
supplementation (stressed rats: ω-3 supplementation:
62.20 ± 3.42 entries, vehicle-treated rats: 39.44 ± 7.63
entries, control rats: 32.42 ± 6.24 entries, (F(1,48) = 5.11,
p = 0.03) (Figure 3A).
Figure 3B shows the level of circulating corticosterone
in rats subjected to 60-s probe trials in the water maze
and in animals that were not disturbed. There were no sig-
nificant differences in the corticosterone levels between
unstressed and stressed rats that were left undisturbed
(Figure 3B, left side). Rats that were subjected to acute
swim had significantly higher plasma corticosteroneubjected to restraint stress failed to gain weight (A and B). Differences
tressed rats from both control and ω-3 groups, and from day 14 for
ight throughout the study. ω-3: ω-3 supplementation. Data are
s.
Table 2 Locomotor activity of the animals
Groups Subjects Total distance traveled (m) Average speed (m) Time spent in center
of open field (sec)
Unstressed groups
Control 9 23.1 ± 3.1 0.07 ± 0.01 19.0 ± 3.04
Vehicle 9 20.3 ± 1.8 0.07 ± 0.01 26.5 ± 2.88
ω-3 9 24.1 ± 3.4 0.08 ± 0.01 16.0 ± 1.53
Stressed groups
Control 9 22.6 ± 3.6 0.07 ± 0.01 9.00 ± 2.22
Vehicle 9 18.4 ± 1.3 0.06 ± 0.004 16.8 ± 2.01
ω-3 9 21.2 ± 1.9 0.07 ± 0.01 16.3 ± 4.48
For each experiment shows the means value ± SEM.
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107.98, p < 0.001) (Figure 3B, right side). In the control
group, rats that were subjected to restraint stress and
swimming for 60 s in the water maze had higher cor-
ticosterone levels than rats that were unstressed
(stressed = 420.0 ± 30.2 ng/ml, n = 6, unstressed =
285.1 ± 16.9 ng/ml, n = 6, p < 0.01) (Figure 3B). This
effect was prevented by ω-3 supplementation (acuteFigure 3 Effects of ω-3 supplementation on stress markers. (A) Restrai
control and vehicle group rats (p < 0.05). Supplementation with ω-3 increa
compared to unstressed animals (p < 0.05), producing an anxiolytic effect.
corticosterone levels, but supplementation with ω-3 prevented this alterati
significant differences.swimming; ω-3 group: stressed = 321.5 ± 25.3 ng/ml,
n = 6, unstressed = 247.5 ± 2.5 ng/ml, n = 6, p > 0.05).
After acute swimming, vehicle treatment significantly
increased the plasma corticosterone levels in the un-
stressed rats compared to that of unstressed rats of
control group (unstressed rats of vehicle group: 383.6 ±
38.5 ng/ml, n = 6, unstressed rats of control group:
285.1 ± 16.9 ng/ml, n = 6, p > 0.05).nt stress decreased the % of entries into the open arms of both
sed the % of entries into the open arms among the stressed rats
(B) After acute swim, restraint stress significantly increased plasma
on. Error bars indicate the means ± SEM. An asterisk (*) indicates
Pérez et al. Behavioral and Brain Functions 2013, 9:25 Page 7 of 12
http://www.behavioralandbrainfunctions.com/content/9/1/25Effects of ω-3 fatty acids supplementation on active
avoidance conditioning
Figures 4A and B show the percentage of conditioned
responses (% CR) during the avoidance conditioning to
the tone under the three dietary regimes in unstressed
and stressed conditions. The two-way repeated-measures
ANOVA shows the main effects of the trials and inter-
actions (trials* diet) on % CR of the unstressed rats
(Figure 4A). There was no main effect of diet on % CR in
rats of the unstressed group (F(2,34) = 2.87, p = 0.07). Like-
wise, in the stressed groups, there was a main effect of tri-
als and interaction (trials*diet) on % CR (Figure 4B). A
2 × 3 factorial ANOVA showed that chronic restraint
stress significantly reduced the % CR on day 1 of con-
ditioning (F(1,48) = 15.417, p < 0.01) (Figure 4C). There
was a main effect of diet on % CR (F(2,48) = 5.779, p < 0.01),
where the post-hoc test showed that the vehicle groups
had significantly lower % CR compared to the control
group. This effect was prevented by ω-3 supplementation
(Figure 4C).
Figure 4D shows the % CR on day 2 of conditioning
(Day 2). A 2 × 3 factorial ANOVA showed a main ef-
fect of chronic restraint stress on % CR (F(1,48) =
46.949, p < 0.001), where the post-hoc test indicates
that restraint stress significantly decreased the % CR
compared to unstressed rats. There was a main effectFigure 4 Effects of ω-3 supplementation on learning. A and B: Restrain
prevented this effect. The values are the means ± SEM of 9 animals per gro
responses (% CR) for the three stages of the test (habituation, conditioning
days 1 and 2 of conditioning, vehicle supplementation decreased learning,
slopes of conditioned responses of rats subjected to restraint stress on day
significant differences from the stressed rats in both the control and vehicl
SEM. An asterisk (*) indicates significant differences.of diet on % CR (F(2,48) = 13.671, p < 0.001), where the
post hoc test shows that the vehicle group had a signifi-
cantly lower % CR than the control group. This effect was
prevented by ω-3 supplementation (Figure 4D). Regres-
sion analysis to compare the slopes of stressed rats on day
2 of conditioning showed that animals from the ω-3 group
had a steeper slope than rats of the other groups subjected
to stress (F(1,176) = 2.9, p =0.046) (Figure 4E).
Discussion
In this study we analyzed the effects of ω-3 supplemen-
tation on anxiety, plasma corticosterone levels, and
learning of chronically stressed rats. First, we investi-
gated whether our stress protocol was effective in trig-
gering stress responses. Stressed rats of all experimental
groups had less body weight gain than unstressed con-
trol group rats (Figure 2A,B). This demonstrates that the
stress protocol used was effective and that ω-3 supple-
mentation did not prevent this effect (Figure 2A,B).
Comparable results have been reported using similar
stress paradigms and corticosterone administration
[44-46]. Diets enriched with PUFAs, in particular the ω-3
family, decreased both the adipose tissue mass and plasma
leptin levels in rats [47]. Leptin is released from adipocytes
and regulates food intake and body weight by binding to
leptin receptors to the hypothalamus [48,49]. Thus, it ist stress decreased the percentage of conditioned responses but ω-3
up. Each point represents the percentages of conditioned avoidance
one and two). C, D: Effect of ω-3 supplementation on learning during
while ω-3 supplementation prevented this effect. E: Comparing the
2 of conditioning. The supplemented rats subjected tostress showed
e groups. ω-3: ω-3 supplementation. Data are represented as means ±
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ments decreased the body weight of the rats compared to
that of controls (Figure 2A,B).
Effects of restraint stress and ω-3 fatty acid on anxiety
and corticosterone plasma levels
Stressed control and vehicle groups rats had significantly
lower percentages of entries into the open arms of the
EPM and spent less time in the center of the open field
test than unstressed rats (Figure 3A, Table 2). These be-
haviors were related to an anxiogenic effect induced by
restraint stress and vehicle treatment (Figure 3A). Interest-
ingly, supplementation with ω-3 had an opposite effect on
the stressed rats. Indeed, ω-3 supplementation increased
the number of entries into the open arm of the EPM,
which was related to an anxiolytic effect (Figure 3A) that
was not associated with locomotor impairments due to re-
straint stress and vehicle (Table 2).
Comparable results were obtained using another
chronic restraint stress paradigm and ω-3 supplementa-
tion [50]. Anxiety is mainly regulated by the basolateral
amygdala and the bed nucleus of the stria terminalis
(BNST) [51-53]. In some chronic stress paradigms, such
as chronic unpredictable stress or immobilization, en-
hanced anxiety has been correlated with dendritic hyper-
trophy in the basolateral amygdala and BNST [18,54,55].
It is possible that the chronic stress protocol and vehicle
treatment in our study induced hyperactivation of the
basolateral amygdala and/or BNST by plastic neuronal
changes, which significantly increased anxiety, HPA axis
activity, and plasma corticosterone levels (Figure 3A,B).
Another brain area that modulates BNST neuronal ex-
citability is the dorsal raphé nucleus (DRN) [56]. Axons
of the serotoninergic neurons located in the DRN are
sent to the BNST and serotonin is released to the synap-
tic space, which in turn inhibits the neuronal excitability
in the BNST by activation of the 5-HT1A and 5-HT1B re-
ceptors [56,57]. Serotonin levels are reduced in the brain of
stressed rats [58,59], and thereby the 5-HT1A and 5-HT1B
receptors in the BNST are not activated. This alteration
may contribute to increasing neuronal excitability in the
BNST and anxiety in the stressed rats (Figure 3A).
On the other hand, ω-3 supplementation significantly
decreased corticosterone levels in the unstressed and
stressed rats (Figure 3A, right side). This suggests that
ω-3 supplementation prevents hyperactivation of the
HPA axis induced by chronic stress, decreasing the ef-
fects of corticosterone on dendritic morphology and
neuronal activity of the basolateral amygdala and BNST.
Supplementation with ω-3 increases serotonin levels in
the brain of stressed rats [60], which in turn may reduce
BNST neuronal excitability by activation of the 5-HT1A
and 5-HT1B. Thus, ω-3 supplementation decreases anx-
iety of the stressed rats.Figure 3A and Table 2 show that ω-3 supplementation
had an anxiogenic effect on the unstressed rats and sig-
nificantly reduced corticosterone levels compared to the
level in unstressed rats treated with vehicle (Figure 3B).
This was unexpected and could be explained by the ef-
fects of both ω-3 and serotonin on the HPA axis and
neuronal activity in the BNST, respectively. Oral admin-
istration of vehicle was a stressor for the rats due be-
cause it increased corticosterone levels in the unstressed
rats. However, this effect was prevented by ω-3 supple-
mentation (Figure 3B, right side). It is possible that ω-3
prevents stress-induced dendritic hypertrophy in the
amygdala of unstressed rats and this decreases cortico-
sterone levels compared to that of unstressed rats
treated with vehicle (Figure 3B, right side). Supplementa-
tion with ω-3 may increase serotonin levels in the brain
of rats [60]. We suggest that to counteract this effect,
the expression of the 5-HT1A and 5-HT1B receptors
was down-regulated in the BNST of unstressed rats
supplemented with ω-3. In this context, neuronal ex-
citability in the BNST may increase because the inhibi-
tory control of serotonin over the BNST is lost. As result,
anxiety is enhanced in unstressed rats supplemented with
ω-3 (Figure 3A).
Unstressed and stressed rats of control group that
were not stimulated had similar corticosterone levels,
suggesting that the rats adapted to 21 days of restraint
stress (Figure 3B, left side). Previous studies have shown
that 3 or 6 hours per day of restraint stress significantly
increased corticosterone plasma levels during the first
week, while in the second and third weeks of restraint
stress the increases of corticosterone levels were less
pronounced [61,62]. Therefore, if the effects of 21 days
of restraint stress on HPA axis activity and cortico-
sterone levels had been lost, the rats that were subjected
to restraint stress and unstressed rats would have had
comparable plasma corticosterone levels after exposure
to a new uncontrollable stressor (acute swimming).
However, control group rats subjected to restraint stress
had significantly higher plasma corticosterone levels
than unstressed rats following one minute of swimming
(Figure 3B). This suggests that one day after the restraint
stress ended, unstressed and stressed rats had similar
HPA axis activity in an environment without stressors.
On the other hand, stressed control group rats still
showed higher levels of the HPA axis activity than un-
stressed rats exposed to a new uncontrollable stressor.
This neuroendocrine alteration, which induces maladap-
tive responses to stressors, is characteristic of stressed
animals [42,50].
Corticosterone plasma levels increased for approxi-
mately the first seven days of restraint stress [10]. How-
ever, the long-term impact of the chronic stress on the
neuronal morphology of the lateral amygdala and on
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stress-free recovery [55]. Therefore, chronically stressed
rats may have had enhanced anxiety and hyperactivity of
the HPA axis at the same time as they were subjected to
new stressors like the EPM and swimming in a water
maze (Figure 3A,B).
In our experiments, supplementation was applied by
oral administration and this method resulted in higher
corticosterone levels after acute swimming in unstressed
vehicle group rats than those of unstressed control
group rats (Figure 3B, right side). This suggests that ve-
hicle treatment, which was applied from weaning to the
end of the stress period, was sufficient to induce short-
term stress in the supplemented rats. Handing could be
comparable to oral administration of vehicle applied be-
fore chronic restraint stress protocol. A longer period of
handling has gradually less inhibitory effects on the HPA
axis activity and significantly decreases the animal’s sen-
sitivity to the restraint stress [63], while a shorter period
of handing before applying acute restraint stress results
in significantly lower corticosterone and adrenocortico-
tropic hormone plasma levels than those of rats without
handling [63].
The method used to apply the supplementation in our
experiments could have induced more profound
desensitization of the mechanisms involved in inducing
the HPA axis response to restraint stress. This in turn
could have resulted in lower corticosterone plasma levels
in the stressed rats supplemented with vehicle than in
animals that were not supplemented in the control
group, after acute swimming (Figure 3B, right side).
Desensitization of the HPA axis might involve the loss of
CRH receptors in the anterior pituitary, which in turn
may induce the corticotrophs to become refractory to
CRH hypersecretion during restraint stress.
The effects of restraint stress and ω-3 fatty acid
supplementation on learning
Restraint stress and oral administration of vehicle were
stressful for the rats given that the two treatments in-
creased plasma corticosterone levels (Figure 3B). In
addition, these treatments impaired learning during the
conditioned trials (Figure 4C,D). Lesion studies in the
main nuclei of the auditory system that regulates learn-
ing, the inferior colliculus (IC, auditory mesencephalon)
and the medial geniculate nucleus (MG, auditory thal-
amus), have demonstrated that the two brain structures
are key factors for acquiring aversive memories to audi-
tory cues during fear conditioning in rats [64]. As well,
restraint stress induces dendritic atrophy in the IC, MG,
and primary auditory cortex, and affects auditory pro-
cessing [27,65,66]. A recent study using micro Positron
Emission Tomography supports these findings, in that
chronic mild stress induced a significant decrease inglucose metabolism in the IC, but not in the superior
colliculus (visual mesencephalon) [67]. In our study,
learning impairment could have been due to stress-induced
dendritic atrophy in the IC and/or MG. In support of this
idea, unstressed and stressed rats supplemented with ve-
hicle showed significant less learning than animals without
supplementation. However, ω-3 supplementation prevented
this effect (Figure 4C,D,E), possibly by preventing the
stress-induced impairment in the IC and/or MG. In fact,
ω-3 fatty acid deficiency impairs active avoidance and de-
creases the polyunsaturated fatty acid composition in the
cellular and subcellular fractions [38]. As well, learning al-
terations associated with maternal deficiency of α-linolenic
acid are prevented by α-linolenic acid supplementation
after weaning [68]. Likewise, DHA supplementation pre-
vents learning impairments in rats induced by ω-3 defi-
ciency in rats [30].
Other brain nuclei that are key for acquiring and evok-
ing auditory avoidance conditioned responses are the lat-
eral (LA) and basal amygdala [26]. Therefore, another
possible explanation for our results in the 2-AA is that
restraint stress and ω-3 supplementation had opposite
effects on these nuclei, that restraint stress induced
dendritic hypertrophy in the LA and this dendritic
change enhanced anxiety-like behaviors by the BNST
[54]. On the other hand, ω-3 supplementation may
have prevented these morphologic alterations and pro-
duced anxiolitic effects in stressed rats. This, in turn
could have improved learning, as has been seen with
anxiolitic drugs such as midazolam, which facilitates
avoidance retrieval in rats [69].
Possible cellular mechanisms underlying the anti-stress
effects of ω-3 fatty acids supplementation
A growing body of evidence suggests that ω-3 PUFA
levels in the brain modulate the reactivity and sensitivity
to stress [70]. In addition, chronic stress reduces the
DHA content in the brain phospholipids and prevents
the incorporation of supplemental-DHA in the neuronal
membranes [60,71]. We suggest that restraint stress de-
creases DHA content in the phosoholipid membranes of
glutamatergic neurons at the amygdaloid complex,
whereas it increases arachidonic acid (AA) content. In
support of this idea, studies with monkeys have shown
that chronic stress is associated with a higher phosphati-
dylethanolamine ω-6/ω-3 ratio, suggesting lower ω-3
fatty acid status in stressed animals [72]. AA is released
from the phospholipid membranes to the cytoplasm by
cytoplasmic phospholipase A2 (cPLA2) activity and is
transformed into endocannabinoid (eCb), which in turn
inhibits GABA release from presynaptic neurons [73-75].
Through this mechanism, chronic stress may increase ex-
citatory neuronal activity in the amygdala and enhance
anxiety. On the other hand, ω-3 supplementation may
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excitatory neurons; which in turn decrease AA levels in
the cytoplasm of neurons. Thus, inhibitory transmission
could be reduced in the amygdala; decreasing anxiety
and plasma corticosterone levels in the stressed rats
(Figure 3A,B).
The anxiolytic effect of ω-3 supplementation may be
related to increased serotonin levels in the brain of
chronically stressed rats. Serotonin has a key role in the
regulation of anxiety-like behaviors [76]. In the case of
our study, ω-3 PUFA supplementation could have en-
hanced the serotonin level in the brain [76,77].
The positive effect of ω-3 supplementation on the
learning could be related to a direct effect of ω-3 on the
auditory brain nuclei that modulates fear learning, such
as the MG and IC, which are affected in the stressed rats
[65,67]. Chronic stress may have decreased proplastic
protein levels in the brain nuclei that produce dendritic
atrophy. Proplastic proteins are implicated in neurite ex-
tension, cell survival and synaptic plasticity [78]. Alter-
natively, ω-3 supplementation may increase the level of
the proteins that prevent dendritic atrophy in the MG
and IC of stressed rats. On the other hand, the positive
effects of ω-3 fatty acids on learning may have been by a
direct effect in the LA, a brain area key for fear learning
[26]. Long-term potentiation studies show that auditory
fear learning depends on AMPA receptor insertion in
the plasmatic membrane of LA neurons [79]. Thus,
chronic stress may impair this process in the LA, while
ω-3 supplementation could prevent this effect. As well, a
mixture of the two mechanisms may be associated with
the positive effects of ω-3 fatty acids on the learning of
stressed rats.
Clinical impact of ω-3 fatty acid supplementation on
stress-related disorders
Preclinical and clinical studies support the use of ω-3
supplementation in stress-related disorders such as de-
pressive and anxiety disorders. For example, diets rich in
ω-3 improve the effects of antidepressants in animal
models of depressive-like behaviors [80,81], as well as in
patients with major depression [82,83] and anxiety disor-
ders [40]. In this context, we propose that due to its
anxiolytic and anti-stress effects, ω-3 supplementation
can improve the symptoms of patients with depressive
and anxiety disorders. Conversely, diets poor in ω-3
could be a risk factor for developing depressive and anx-
iety disorders.
Conclusions
The present findings demonstrate that ω-3 supplementa-
tion in an early phase of brain development has strong
anti-stress effects, decreasing plasma corticosterone
levels and anxiety. In addition, ω-3 supplementation canimprove learning in stressed rats. Our results suggest
that key brain areas for learning, such as the amygdala
and auditory thalamus, could be targets for the positive
effects of ω-3 supplementation to improve learning in
stressed rats.
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